Document Detail


Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia.
MedLine Citation:
PMID:  24754314     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Introduction: Several long-acting injectable (LAI) second-generation antipsychotics are now available for the management of schizophrenia. As patients with schizophrenia frequently present with diverse and challenging symptoms, it is important to understand the effects of antipsychotics in treating these different symptom subgroups and the timing of these responses. Areas covered: For this review, data from two randomized, double-blind trials were analyzed in respect to the onset and persistence of effects on several measures of psychopathology (as measured by the Positive and Negative Syndrome Scale [PANSS]) after treatment with LAI paliperidone palmitate (PP) (NCT00590577 and NCT00589914). Expert opinion: Symptom reductions from baseline with PP were significant by day 4 for all five PANSS factors in both studies. Some effects may have been driven by the presence or absence of a placebo response. A significant effect for PP versus placebo was observed for all major symptom domains for one or more doses of PP during the first month of treatment. Once established, most (but not all) significant responses persisted to the end point. Similar improvements were observed in PANSS scores with PP and oral risperidone. Dose-dependent trends were observed for the effect of PP on positive, negative and uncontrolled hostility/excitement symptoms.
Authors:
Larry Alphs; Cynthia A Bossie; Dong-Jing Fu; Yi-Wen Ma; Jennifer Kern Sliwa
Related Documents :
10459114 - Half-side comparison of erythemogenic versus suberythemogenic uva doses in oral photoch...
24074484 - Aripiprazole augmentation to antidepressant therapy in japanese patients with major dep...
25466694 - Influencing effect of non-motor symptom clusters on quality of life in parkinson's dise...
25419584 - Correction to hofmann, wu, and boettcher (2014).
24923344 - Nicotine effects on human affective functions. a systematic review of the literature on...
16199834 - Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  15     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-04-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1029-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in...
Next Document:  Dolutegravir, abacavir and lamivudine as HIV therapy.